Minimal change disease following COVID-19 vaccination: A systematic review.

Konstantinos S KechagiasJoshua D LaleyeJan DrmotaGeorgios GeropoulosGeorgios KyrtsonisMarina ZafeiriKonstantinos Katsikas TriantafyllidisDimitra Stathi

Published in: PloS one (2024)

MCD is possibly a condition clinicians may see in patients receiving COVID-19 vaccines. Although this adverse event is uncommon, considering the limited published data and the absence of confirmed causality, increased clinical awareness is crucial for the early recognition and optimal management of these patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
prognostic factors
peritoneal dialysis
randomized controlled trial
adverse drug
electronic health record
respiratory syndrome coronavirus
big data
machine learning
patient reported